Intellectual Property

• Official Reply on the Application of Provisions on the Passing off of Patents in the Patent Law and Alleged Patent Violations in the Advertising Law

  关于专利法中假冒专利和广告法中涉嫌专利违法法条适用的批复

  CNIPA differentiates patent and advertising violations

  November 01, 2021

• China National Intellectual Property Administration, Proposal for Revising the Measures for the Registration of Pledges of Patents (Draft for Comments)

  国家知识产权局专利权质押登记办法修改建议 (征求意见稿)

  Rules for registration of patent pledges are revised

  September 24, 2021

• Protection of Information as Trade Secrets in China

  Fang Qi and Danlei Wu of Fangda Partners discuss what information qualifies for trade secrets protection including the scope of trade secrets, protective measures in place for trade secrets and confidentiality of trade secrets with reference to judicial decisions taking a lead role in the development of trade secrets law

  September 17, 2021

  

• State Administration for Market Regulation, Decision on Amending the «PRC Electronic Commerce Law» (Draft for Comments)

  国家市场监督管理总局关于修改〈中华人民共和国电子商务法〉的决定 (征求意见稿)

  Draft E-Commerce Law accords greater protection to IP rights holders

  September 10, 2021

• Several Provisions on Issues Concerning Specific Application of the Law in the Trial of Dispute Cases Involving the Infringement of Rights in New Varieties of Plants (2)

  关于审理侵害植物新品种权纠纷案件具体应用法律问题的若干规定（二）

  Propagating materials are crucial to IP infringement cases on new plant varieties

  September 03, 2021

• Provisions on Several Issues Concerning the Application of the Law in the Trial of Civil Disputes Over Patents of Pharmaceuticals for Which Registration is Applied

  关于审理申请注册的药品相关的专利权纠纷民事案件适用法律若干问题的规定

  Judicial proceedings for the patent linkage system specified

  August 19, 2021

• National Medical Products Administration and China National Intellectual Property Administration, Implementing Measures for the Mechanism for the Early Resolution of Pharmaceutical Patent Disputes (Trial Implementation)

  国家药品监督管理局、国家知识产权局药品专利纠纷早期解决机制实施办法 (试行)

  An early resolution mechanism is in place for pharmaceutical patent disputes

  August 06, 2021

• New Judicial Interpretation for Plant Variety Rights in China

  Andrew Sim and Alanna Rennie of Baker McKenzie discuss the key provisions of the new Judicial Interpretation on plant variety rights (PVR), which will encourage more consistent rulings by the people's court and grant stronger judicial protection to PVR holders in China

  July 22, 2021

  

• General Office of the China National Intellectual Property Administration, Several Provisions on the Participation by Technical Investigators in the Handling of Cases Involving Administrative Adjudication of Patent and Integrated Circuit Layout Design Infringement Disputes (Tentative)

  国家知识产权局办公室关于技术调查官参与专利、集成电路布图设计侵权纠纷行政裁决办案的若干规定 (暂行)

  Patent and IC layout design cases may involve technical investigators

  May 31, 2021

• In the News: China IP Report; BNP Paribas Securities; and PRC Futures Law

  China failing to protect U.S. companies' IP according to USTR report; French banking giant BNP Paribas applies for securities business; and PRC Futures Law submitted to NPCSC for first reading

  May 03, 2021